169 related articles for article (PubMed ID: 1972348)
1. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.
Pfragner R; Höfler H; Behmel A; Ingolic E; Walser V
Cancer Res; 1990 Jul; 50(13):4160-6. PubMed ID: 1972348
[TBL] [Abstract][Full Text] [Related]
2. Biologic and cytogenetic characterization of three human medullary thyroid carcinomas in culture.
Pfragner R; Wirnsberger G; Behmel A; Niederle B; Längle F; Roka R; Mandl A; Pürstner P; Auner J; Tatzber F
Henry Ford Hosp Med J; 1992; 40(3-4):299-302. PubMed ID: 1483877
[TBL] [Abstract][Full Text] [Related]
3. Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation.
Carson EB; McMahon M; Baylin SB; Nelkin BD
Cancer Res; 1995 May; 55(10):2048-52. PubMed ID: 7743500
[TBL] [Abstract][Full Text] [Related]
4. Different mechanisms of calcitonin, calcitonin gene-related peptide, and somatostatin regulation by glucocorticoids in a cell culture of human medullary thyroid carcinoma.
Cote GJ; Gagel RF
Henry Ford Hosp Med J; 1987; 35(2-3):149-52. PubMed ID: 2891648
[No Abstract] [Full Text] [Related]
5. Molecular forms of katacalcin, calcitonin gene-related peptide and gastrin-releasing peptide, in a human medullary thyroid carcinoma.
Conlon JM; McGregor GP; Wallin G; Grimelius L; Thim L
Cancer Res; 1988 May; 48(9):2412-6. PubMed ID: 3258543
[TBL] [Abstract][Full Text] [Related]
6. [Characterization of a human cell line from an anaplastic carcinoma of the thyroid gland].
Gioanni J; Zanghellini E; Mazeau C; Zhang D; Courdi A; Farges M; Lambert JC; Duplay H; Schneider M
Bull Cancer; 1991 Nov; 78(11):1053-62. PubMed ID: 1369551
[TBL] [Abstract][Full Text] [Related]
7. Expression of v-Ha-ras driven by the calcitonin/calcitonin gene-related peptide promoter: a novel transgenic murine model for medullary thyroid carcinoma.
Johnston D; Hatzis D; Sunday ME
Oncogene; 1998 Jan; 16(2):167-77. PubMed ID: 9464534
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of thyroid medullary carcinoma TT cell line.
Zabel M; Grzeszkowiak J
Histol Histopathol; 1997 Jan; 12(1):283-9. PubMed ID: 9046062
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
10. The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT.
Bläker M; Arrenberg P; Stange I; Schulz M; Burghardt S; Michaelis H; Pace A; Greten H; von Schrenck T; de Weerth A
Regul Pept; 2004 Apr; 118(1-2):111-7. PubMed ID: 14759564
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional and posttranscriptional modulation of calcitonin gene expression by sodium n-butyrate in cultured human medullary thyroid carcinoma.
Nakagawa T; Nelkin BD; Baylin SB; de Bustros A
Cancer Res; 1988 Apr; 48(8):2096-100. PubMed ID: 3258183
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
13. Changes in calcitonin gene RNA processing during growth of a human medullary thyroid carcinoma cell line.
Nelkin BD; Chen KY; de Bustros A; Roos BA; Baylin SB
Cancer Res; 1989 Dec; 49(24 Pt 1):6949-52. PubMed ID: 2582437
[TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid carcinomas in cell culture--models for future therapies.
Pfragner R; Wirnsberger GH; Ingolic E; Niederle B
Wien Klin Wochenschr; 2002 Apr; 114(7):279-83. PubMed ID: 12089864
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
16. Detection of calcitonin and calcitonin gene-related peptide mRNA in human medullary thyroid carcinoma. A retrospective study.
Denijn M; De Weger RA; Van Unnik JA; Den Otter W; Lips CJ
J Pathol; 1993 Jan; 169(1):53-60. PubMed ID: 8433214
[TBL] [Abstract][Full Text] [Related]
17. Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature.
Bhanot P; Yang J; Schnadig VJ; Logroño R
Diagn Cytopathol; 2007 May; 35(5):285-92. PubMed ID: 17427218
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid.
Sundler F; Alumets J; Håkanson R; Björklund L; Ljungberg O
Am J Pathol; 1977 Aug; 88(2):381-6. PubMed ID: 195473
[TBL] [Abstract][Full Text] [Related]
19. Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ishizaki T
Mod Pathol; 1996 Jun; 9(6):631-5. PubMed ID: 8782199
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical hormone content in medullary and undifferentiated thyroid carcinoma and prognosis after surgery.
Henninger S; Schatz H; Stracke H; Wagner U; Kracht J
Acta Histochem; 1988; 83(1):51-6. PubMed ID: 2897752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
